COVID-19 vaccine preferences in India

Bansal, Prateek; Raj, Alok; Shukla, Dhirendra Mani; Sunder, Naveen

doi:10.1016/j.vaccine.2022.02.077

Cited by 19 publications

(12 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Vaccine hesitancy is caused by many factors, including understanding the value of a vaccine, its safety and effectiveness, accessible immunization services, and lack of trust in healthcare agencies [49]. Our findings suggested that education level and public trust in government are key factors associated with acceptance of COVID-19 vaccination, whereas availability, safety, efficacy, and duration of vaccine effectiveness of different vaccines are key factors in people's vaccine choice preferences, which showed the same result as previous studies [50][51][52][53][54]. Moreover, the spread of COVID-19-related misinformation has been reported to significantly affect vaccine hesitancy [55,56].…”

Section: Reducing Vaccine Hesitancysupporting

confidence: 84%

Acceptance of and Preference for COVID-19 Vaccination in India, the United Kingdom, Germany, Italy, and Spain: An International Cross-Sectional Study

et al. 2022

View full text Add to dashboard Cite

Objective: India and Europe have large populations, a large number of Coronavirus disease 2019 (COVID-19) cases, and different healthcare systems. This study aims to investigate the differences between the hesitancy toward and preference for COVID-19 vaccines in India and four European countries, namely, the United Kingdom (UK), Germany, Italy, and Spain. Methodology: We conducted a cross-national survey for distribution in India, the UK, Germany, Italy, and Spain. More specifically, a discrete choice experiment (DCE) was conducted to evaluate vaccine preferences, and Likert scales were used to probe the underlying factors that contribute to vaccination acceptance. Propensity score matching (PSM) was performed to directly compare India and European countries. Results: A total of 2565 respondents (835 from India and 1730 from the specified countries in Europe) participated in the survey. After PSM, more than 82.5% of respondents from India positively accepted the COVID-19 vaccination, whereas 79.9% of respondents from Europe had a positive attitude; however, the proportion in Europe changed to 81.6% in cases in which the vaccine was recommended by friends, family, or employers. The DCE found that the COVID-19 vaccine efficacy was the most important factor for respondents in India and the four European nations (41.8% in India and 47.77% in Europe), followed by the vaccine cost (28.06% in India and 25.88% in Europe). Conclusion: Although most respondents in both regions showed high acceptance of COVID-19 vaccines, either due to general acceptance or acceptance as a result of social cues, the vaccination coverage rate shows apparent distinctions. Due to the differences in COVID-19 situations, public health systems, cultural backgrounds, and vaccine availability, the strategies for COVID-19 vaccine promotion should be nation-dependent.

show abstract

Section: Reducing Vaccine Hesitancysupporting

confidence: 84%

Acceptance of and Preference for COVID-19 Vaccination in India, the United Kingdom, Germany, Italy, and Spain: An International Cross-Sectional Study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Hence, countries should consider their specific context while deciding whether to continue vaccinating their low-risk groups without compromising on the routine immunization status ( 18 ). Studies have shown that the side effects following vaccination by specific vaccines resulted in people either differing or delaying the next dose ( 19 ). Even though the CoWIN platform provided an opportunity to register, select, and choose their preferred vaccination center, some people still preferred to wait till their vaccine of choice was made available at the vaccination sites closest to their homes, resulting in a delay in uptake ( 20 ).…”

Section: Discussionmentioning

confidence: 99%

Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India

Godbole,

Diwan,

Das

et al. 2024

Front. Public Health

View full text Add to dashboard Cite

IntroductionIndia launched the COVID-19 vaccination drive on 16th January 2021 by vaccinating the adult population above 18 years of age. This was followed by the introduction of an additional precaution dose. As on 18th October 2022, 1,02,66,96,808 (1.02 Billion) first dose and 94, 95, 39,516 (949 Million) second doses of COVID-19 vaccine were administered. However, when compared to the uptake of the primary doses, the precaution dose uptake lagged behind with only 21,75, 12,721 (217 million) doses administered. Even though, the uptake of the primary doses remained optimal, irrespective of different interventions by the Government of India, the uptake of the precaution dose remained poor. In this context, the Ministry of Health & Family Welfare wanted to understand the facilitators and Barriers for precaution dose uptake among adults so that future immunization campaigns could address these issues.MethodsAn exploratory qualitative study was conducted to assess the facilitators and barriers for COVID-19 precaution dose uptake at community level across 6 different states in India. From each of the states, two districts with the highest and lowest rates of COVID-19 vaccine precaution dose uptake were selected. In each of these districts, 2 block Primary Healthcare Centres (PHCs), one with high and one with low uptake were identified. Within these block PHCs, a PHC field area with high and low precaution dose uptakes was identified. From the identified sites a minimum of four IDIs, four FGDs were conducted among the community members. KIIs of the State Immunization Officers, District Immunisation Officers, PHC Medical Officers, healthcare workers like Accredited Social Health Activist/Auxiliary Nurse Midwife were also conducted. The data was audio recorded and it was transcribed, translated and analysed using framework approach.ResultsIt was observed that rise in COVID-19 cases prompted the community to take the precaution dose, this along with the cost of hospitalization and the number of productive days being lost as a result of being infected resulted in vaccine uptake. The fear of non-availability of COVID-19 vaccines latter on also prompted people for vaccine uptake. While the barriers were, poor accessibility to vaccination centers, long hours of travel, poor road connectivity and lack of transportation facilities. However, the most prominent barriers observed across all study sites was that a sense of pandemic fatigue and complacency had developed both among the providers as well as the beneficiaries. Other barriers include differences in vaccination schedules and longer duration between the primary doses of some vaccines. Media was identified to be both a barrier and facilitator for Covid-19 Precaution dose uptake. Even though media played an important role in disseminating information in the beginning of the campaign, it was soon followed by the circulation of both misinformation and disinformation.DiscussionThe study identified that dissemination of accurate information and community involvement at each stage of planning and implementation are crucial for the success of any campaign. Efforts should be constantly made to address and re-invent strategies that will be most suitable for the needs of the community. Therefore, in order to ensure successful vaccination campaigns, it is crucial that along with political will it is also important to have a decentralized approach with inter-sectoral coordination with different stakeholders such as healthcare workers, community members and the different departments such as the local self-governments, education department, law & order department etc. These lessons learnt from COVID-19 vaccination campaigns must not be forgotten and must be applied in future vaccination campaigns and while framing public health policies.

show abstract

“…The 2019 coronavirus epidemic detrimentally affected the lives of billions of people across the globe. Infecting hundreds of millions of people, it destroyed economies and caused society to cease to function [1,2]. As of September 2021, COVID-19 has affected more than 234 million people in 223 countries, areas, or territories, causing over 6 million…”

Section: Introductionmentioning

confidence: 99%

“…Processes 2022, 10, 1665 2 of 19 deaths [3]. For example, the statistics from a study conducted in India revealed the severe consequences of COVID-19 on the country in terms of affecting India's economy and causing social unrest and increased rates of domestic violence [2]. To combat and slow the spread of the COVID-19 virus, governments have implemented protocols such as physical distancing, mass-facemask usage, and quarantines.…”

Section: Introductionmentioning

confidence: 99%

“…Individuals who were accepting of recommendations from family and friends had higher vaccination rates [35], and 69% of respondents reported having trust in the vaccine [36]. Studies conducted in India identified fear of side effects and peer vaccination rates as important influencers in vaccine acceptance [2]. Other factors such as the perception of the vaccine being necessary, trusting the government, and indifference towards the vaccine costs were all correlated with vaccine acceptance [37].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

A Systematic Investigation of American Vaccination Preference via Historical Data

Chen¹,

Chen²,

Shi³

et al. 2022

Processes

View full text Add to dashboard Cite

While COVID-19 vaccines are generally available, not all people receive vaccines. To reach herd immunity, most of a population must be vaccinated. It is, thus, important to identify factors influencing people’s vaccination preferences, as knowledge of these preferences allows for governments and health programs to increase their vaccine coverage more effectively. Fortunately, vaccination data were collected by U.S. Census Bureau in partnership with the CDC via the Household Pulse Survey (HPS) for Americans. This study presents the first analysis of the 24 vaccination datasets collected by the HPS from January 2021 to May 2022 for 250 million respondents of different ages, genders, sexual orientations, races, education statuses, marital statuses, household sizes, household income levels, and resources used for spending needs, and with different reasons for not receiving or planning to receive a vaccine. Statistical analysis techniques, including an analysis of variance (ANOVA), Tukey multiple comparisons test, and hierarchical clustering (HC), were implemented to analyze the HPS vaccination data in the R language. It was found that sexual orientation, gender, age, and education had statistically significant influences on the vaccination rates. In particular, the gay/lesbian group showed a higher vaccination rate than the straight group; the transgender group had a lower vaccination rate than either the female or the male groups; older respondents showed greater preference for vaccination; respondents with higher education levels also preferred vaccination. As for the other factors that were not significant enough to influence vaccinations in the ANOVA, notable trends were found. Asian Americans had higher vaccination rates than other races; respondents from larger household sizes had a lower chance of getting vaccinated; the unmarried group showed the lowed vaccination rate in the marital category; the respondents depending on borrowed money from the Supplemental Nutrition Assistance Program (SNAP) showed a lower vaccination rate than people with regular incomes. Concerns regarding the side-effects and the safety of the vaccines were the two major reasons for vaccination hesitance at the beginning of the pandemic, while having no trust in the vaccines and no trust in the government became more common in the later stage of the pandemic. The findings in this study can be used by governments or organizations to improve their vaccination campaigns or methods of combating future pandemics.

show abstract

COVID-19 vaccine preferences in India

Cited by 19 publications

References 27 publications

Acceptance of and Preference for COVID-19 Vaccination in India, the United Kingdom, Germany, Italy, and Spain: An International Cross-Sectional Study

Acceptance of and Preference for COVID-19 Vaccination in India, the United Kingdom, Germany, Italy, and Spain: An International Cross-Sectional Study

Facilitators and barriers to the uptake of COVID-19 vaccine precaution dose among adult population: qualitative analysis across six different states of India

A Systematic Investigation of American Vaccination Preference via Historical Data

Contact Info

Product

Resources

About